SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Investor AB (publ) (IVSXF) trades at a trailing P/E of 0.8. Trailing earnings yield is 128.21%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.8); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (128.21%).
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 128.21% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 91/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IVSXF
Valuation Multiples
P/E (TTM)0.8
Forward P/EN/A
PEG Ratio0.02
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.55
EV/EBITDA0.0
Per Share Data
EPS (TTM)$51.39
Book Value / Share$0.00
Revenue / Share$72.39
FCF / Share$0.00
Yields & Fair Value
Earnings Yield128.21%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$11.01 |
$61.72B |
$33.67B |
54.5% |
| 2017 |
$14.48 |
$75.97B |
$44.32B |
58.3% |
| 2018 |
$-0.74 |
$37.64B |
$-2.25B |
-6% |
| 2019 |
$33.05 |
$141.63B |
$101.23B |
71.5% |
| 2020 |
$17.23 |
$88.46B |
$52.79B |
59.7% |
| 2021 |
$74.41 |
$265.34B |
$228.07B |
86% |
| 2022 |
$-24.38 |
$-27.31B |
$-74.68B |
- |
| 2023 |
$41.46 |
$185.31B |
$127.05B |
68.6% |
| 2024 |
$36.98 |
$168.91B |
$113.34B |
67.1% |
| 2025 |
$51.39 |
$221.86B |
$157.49B |
71% |
